The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Validation of a clinical score (CS) for patients (pts) with well-differentiated neuroendocrine tumors (WD NETs) under consideration for peptide receptor radionuclide therapy (PRRT) with Lu 177 dotatate.
 
Satya Das
Honoraria - Medsphere
Speakers' Bureau - Ipsen
Research Funding - Exelixis
 
Aman Chauhan
Research Funding - Bristol-Myers Squibb (Inst); Clovis Oncology (Inst)
Travel, Accommodations, Expenses - Entrinsic Health Solutions
(OPTIONAL) Uncompensated Relationships - Ipsen (Inst); Lexicon (Inst)
 
Liping Du
No Relationships to Disclose
 
Katharine Thomas
No Relationships to Disclose
 
Aasems Jacob
No Relationships to Disclose
 
Aimee Schad
No Relationships to Disclose
 
Shikha Jain
Stock and Other Ownership Interests - Doximity
Honoraria - Healio; Magellan Health; Tempus
Consulting or Advisory Role - Healio; Magellan Health
Speakers' Bureau - Practicing Clinician Exchange
 
Aaron Jessop
No Relationships to Disclose
 
Chirayu Shah
No Relationships to Disclose
 
David Eisner
No Relationships to Disclose
 
Dana Backlund Cardin
Honoraria - OncLive/MJH Life Sciences
Consulting or Advisory Role - Abbvie; Rafael Pharmaceuticals
Research Funding - Advaxis (Inst); Array BioPharma (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Corcept Therapeutics (Inst); EMD Serono (Inst); Incyte (Inst); Lilly (Inst); Rafael Pharmaceuticals (Inst); Synta (Inst)
Travel, Accommodations, Expenses - Abbvie
 
Kristen Keon Ciombor
Consulting or Advisory Role - Array BioPharma; Bayer; Foundation Medicine; i3 Health; Merck; Natera; Research to Practice; Taiho Pharmaceutical
Research Funding - Abbvie (Inst); Amgen (Inst); Array BioPharma (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo (Inst); Incyte (Inst); Incyte (Inst); MedImmune (Inst); Merck (Inst); Merck (Inst); Novartis (Inst); Nucana (Inst); Onyx (Inst); Pfizer (Inst); Pfizer/Calithera (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Array BioPharma
 
Laura Williams Goff
Consulting or Advisory Role - Bayer/Onyx; Competitive Drug Development International; Eisai; Lilly; Newlink Genetics; QED Therapeutics
Research Funding - Agios; ArQule; ASLAN Pharmaceuticals; Astellas Pharma; Basilea; BeiGene; Bristol-Myers Squibb; H3 Biomedicine; Incyte; Leap Therapeutics; Lilly; Merck (Inst); Merck (Inst); Onyx; Pfizer; Sun Pharma
 
Marques Bradshaw
No Relationships to Disclose
 
Dominique Delbeke
No Relationships to Disclose
 
Martin P. Sandler
No Relationships to Disclose
 
Jordan Berlin
Consulting or Advisory Role - Abbvie; Bayer Health; Celgene; Clovis Oncology; Cornerstone Pharmaceuticals; EMD Serono; ipsen; qed therapeutics
Research Funding - Abbvie (Inst); Bayer (Inst); boston biomedical (Inst); Dragonfly Therapeutics (Inst); EMD Serono (Inst); I-MAB (Inst); Incyte (Inst); Karyopharm Therapeutics (Inst); Lilly (Inst); Macrogenics (Inst); pfizer (Inst); Pharmacyclics (Inst); PsiOxus Therapeutics (Inst)
Travel, Accommodations, Expenses - Bayer; boston Biomedical; EMD Serono
Other Relationship - novocure; Pancreatic Cancer Action Network
 
Robert A. Ramirez
Stock and Other Ownership Interests - Advanced Accelerator Applications (I)
Consulting or Advisory Role - Advanced Accelerator Applications; AstraZeneca; bioTheranostics; Ipsen; Novartis
Speakers' Bureau - Advanced Accelerator Applications; AstraZeneca; Genentech/Roche; Guardant Health; Ipsen; Merck
Research Funding - AADi (Inst); Merck (Inst)